| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | CHIEF DEVELOPMENT OFFICER | Stock Option (right to buy) | 100K | Mar 21, 2025 | Direct | ||
| Shattuck Labs, Inc. | Director | Stock Option (Right to Buy) | 66.3K | Aug 28, 2025 | Direct | ||
| Artiva Biotherapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 13.8K | Jun 24, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | Aug 28, 2025 | 1 | $0 | 4 | Sep 2, 2025 | Director |
| STTK | Shattuck Labs, Inc. | Aug 25, 2025 | 0 | $0 | 3 | Sep 2, 2025 | Director |
| ARTV | Artiva Biotherapeutics, Inc. | Jun 24, 2025 | 1 | $0 | 4 | Jun 26, 2025 | Director |
| CUE | Cue Biopharma, Inc. | Mar 21, 2025 | 1 | $0 | 4 | Mar 25, 2025 | CHIEF DEVELOPMENT OFFICER |
| ARTV | Artiva Biotherapeutics, Inc. | Jan 28, 2025 | 1 | $0 | 4 | Jan 29, 2025 | Director |
| ARTV | Artiva Biotherapeutics, Inc. | Jan 28, 2025 | 0 | $0 | 3 | Jan 29, 2025 | Director |
| CUE | Cue Biopharma, Inc. | Nov 25, 2024 | 1 | $0 | 4 | Nov 29, 2024 | CHIEF DEVELOPMENT OFFICER |
| CUE | Cue Biopharma, Inc. | Nov 25, 2024 | 0 | $0 | 3 | Nov 29, 2024 | CHIEF DEVELOPMENT OFFICER |